Literature DB >> 32113821

Surgery for Type A Aortic Dissection: 14-Year Contemporary Cohort Study.

Tom Kai Ming Wang1, Danting Wei2, Thomas Evans3, Tharumenthiran Ramanathan3, David Haydock3.   

Abstract

BACKGROUND: Type A aortic dissection is a fatal condition warranting emergency surgery to prevent complications and death. We reviewed the contemporary trends, characteristics, outcomes and predictors of this operation at our centre over a 14-year period.
METHODS: Consecutive patients undergoing type A aortic dissection surgery at Auckland City Hospital during March 2003-March 2017 were studied, and relevant characteristics and outcomes collected prospectively for statistical analyses.
RESULTS: There were 327 patients included, and the number of operations each year remained similar from 2003-2010, and steadily increased thereafter. Median age was 60.6 years, with 124 (37.9%) females, 136 (41.6%) Maori or Pacific ethnicity, 319 (97.6%) emergency surgeries, 62 (19.0%) in a critical preoperative state and 154 (47.1%) having a malperfusion syndrome. Operative mortality occurred in 65 (19.9%), although this has decreased from 23.3% before 2014 to 14.0% since. Composite morbidity occurred in 212 (65.0%), predominantly acute kidney injury 134 (41.0%), ventilation >24 hours (129 (39.6%), return to theatre 94 (28.8%) and stroke 63 (19.3%). Survival at 1, 5 and 10 years was 79.0%, 71.7% and 57.8% respectively. Critical preoperative state and malperfusion syndrome were independent predictors of operative and long-term mortality and composite morbidity.
CONCLUSION: Surgery for acute type A aortic dissection has been increasing since 2011 and continues to have high rates of operative mortality and morbidities, although the former has decreased since 2014. Critical preoperative state and malperfusion were the key predictors of adverse outcomes. After surviving the perioperative period, prognosis was good with low rates of late mortality.
Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aorta; Cardiac surgical procedures; Dissecting aneurysm; Operative surgical procedures; Thoracic aorta

Mesh:

Year:  2020        PMID: 32113821     DOI: 10.1016/j.hlc.2020.01.008

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  5 in total

1.  Th1, Th2, and Th17 cells are dysregulated, but only Th17 cells relate to C-reactive protein, D-dimer, and mortality risk in Stanford type A aortic dissection patients.

Authors:  Mowei Song; Li Deng; Hongtao Shen; Guofu Zhang; Hang Shi; Erjun Zhu; Qingping Xia; Hongguang Han
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

2.  Metabolic syndrome and its components are associated with hypoxemia after surgery for acute type A aortic dissection: an observational study.

Authors:  Like Zhang; Lei Zhang; Zengren Zhao; Yun Liu; Juzeng Wang; Mengye Niu; Xiansheng Sun; Xiansheng Zhao
Journal:  J Cardiothorac Surg       Date:  2022-06-13       Impact factor: 1.522

3.  The effects of DeBakey type acute aortic dissection and preoperative peripheral and cardiac malperfusion on the outcomes after surgical repair.

Authors:  Paolo Nardi; Carlo Bassano; Calogera Pisano; Claudia Altieri; Maria Sabrina Ferrante; Monica Greci; Dario Buioni; Fabio Bertoldo; Andrea Farinaccio; Giovanni Ruvolo
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-05-15

Review 4.  Preoperative acute lung injury and oxygenation impairment occurred in the patients with acute aortic dissection.

Authors:  Xuemin Zhao; Mengjun Bie
Journal:  BMC Cardiovasc Disord       Date:  2022-03-27       Impact factor: 2.298

Review 5.  Adventitial Fibroblasts in Aortic Aneurysm: Unraveling Pathogenic Contributions to Vascular Disease.

Authors:  Cameron D A Mackay; Anshul S Jadli; Paul W M Fedak; Vaibhav B Patel
Journal:  Diagnostics (Basel)       Date:  2022-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.